Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

Brain

Volumn 131, Issue 7, 2008, Pages 1759-1775

  Lucchinetti, C F ^a,h   Gavrilova, R H ^a   Metz, I ^b   Parisi, J E ^c   Scheithauer, B W ^c   Weigand, S ^d   Thomsen, K ^d   Mandrekar, J ^d   Altintas, A ^e   Erickson, B J ^f   Konig F ^b   Giannini, C ^c   Lassmann, H ^g   Linbo, L ^a   Pittock, S J ^a   Bruck W ^b  

^a Department of Neurology ^*  (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Laboratory Medicine and Pathology   (United States)

^d Health Sciences Research   (United States)

^e ISTANBUL UNIVERSITY   (Turkey)

^f Department of Health Sciences Research   (United States)

^g Medical University of Vienna   (Austria)

^h MAYO CLINIC   (United States)

Author keywords

Biopsy; Demyelinating disease; MRI; Pathology; Tumefactive multiple sclerosis

Indexed keywords

ADOLESCENT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN EDEMA; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ENCEPHALITIS; FEMALE; FOLLOW UP; HISTOPATHOLOGIC SKIN REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BIOPSY; BRAIN; BRAIN EDEMA; CHILD; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 46849083076     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn098     Document Type: Article

References (104)

1. Al-Bunyan MA. Tumor-like presentation of multiple sclerosis. Saudi Med J 2000; 21: 393-5.
2. Alderson L, Fetell MR, Sisti M, Hochburg F, Cohen M, Louis DN. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 1996; 60: 102-5.
3. Annesley-Williams D, Farrell MA, Staunton H, Brett FM. Acute demyelination, neuropathological diagnosis, and clinical evolution. J Neuropathol Exp Neurol 2000; 59: 477-89.
4. Annunziata P, Giorgio A, De Santi L, Zipoli V, Portaccio E, Amato MP, et al. Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-B. J Neurol Sci 2006; 244: 97-102.
5. Atlas SW, Grossman RI, Gomori JM, Hackney DB, Goldberg HI, Zimmerman RA, et al. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. Radiology 1987; 164: 71-7.
6. Avasarala JR, Cross AH, Trotter JL. Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol 2001; 58: 2044-5.
7. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-69.
8. Barkhof F, Rocca M, Francis G, van Waesberghe JH, Uitdehaag BM, Hommes OR, et al. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta-1a. Ann Neurol 2003; 53: 718-24.
9. Bolay H, Karabudak R, Tacal T, Onol B, Selekler K, Saribas O. Balo's concentric sclerosis: report of two patients with magnetic resonance imaging follow-up. J Neuroimaging 1996; 6: 98-103.
10. Brinar VV. Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg 2004; 106: 197-210.
11. Butteriss DJ, Ismail A, Elison DW, Birchall D. Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in patient with multiple sclerosis. Br J Radiol 2003; 76: 662-5.
12. Capello E, Roccataglioata L, Pagano F, Macardi GL. Tumor-like multiple sclerosis (MS) lesions: neuropathological clues. J Neurosci 2001; 22: S113-6.
13. Censori B, Agostinis C, Partziguian T, Gazzaniga G, Biroli F, Mamoli A. Large demyelinating brain lesion mimicking a herniating tumor. J Neurosci 2001; 22: 325-9.
14. Champs Study Group. Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol 2001; 132: 463-71.
15. Charil A, Yousry T, Rovaris M, Barkhof F, De Stefano N, Fazekas F, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of 'no better explanation'. Lancet Neurol 2006; 5: 841-52.
16. Chen C, Ro L, Wang L, Wong Y. Balo's concentric sclerosis: MRI. Neuroradiology 1996; 38: 322-4.
17. Comi G. Mutiple sclerosis: pseudotumoral forms. Neurol Sci 2004; 25: S374-9.
18. Confavreux C, Vukusic S. Natural history of multiple sclerosis: implications for counselling and therapy. Curr Opin Neurol 2002; 15: 257-66.
19. Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiology 1996; 38: 560-5.
20. Di Patre P, Castillo V, Delavelle J, Vuillemoz S, Picard F, Landis T. 'Tumor-mimicking' multiple sclerosis. Clin Neuropathol 2003; 22: 235-9.
21. Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, fazekas F. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler 2005; 11: 135-9.
22. Ernst T, Chang L, Walot I, Huff K. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology 1998; 51: 1486-8.
23. European S, Group, on Intereron b-1b in Secondary Progressive MS. Placebo-controlled multicentre randomized trial of interferon b-1b in treatment of secondary progressive multiple sclerosis. Lancet 1998; 352: 1491-7.
24. Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999; 53: 448-56.
25. Fazekas F, Offenbacher H, Fuchs S, Schmidt R, Niederkorn K, Horner S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988; 38: 1822-5.
26. Frederiksen JL, Larsson HB, Olesen J. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand 1992; 86: 317-22.
27. Friedman DI. Multiple sclerosis simulating a mass lesion. J Neuroophthalmol 2000; 20: 147-53.
28. Gavrilova R, Metz I, Bruck W, Weigand S, Thomsen K, Mandrekar K, et al. MRI correlates of immunopathological patterns. Mult Scler 2007; 13: S76.
29. Giang DW, Poduri KR, Eskin TA, Ketonen LM, Friedman PA, Wang DD, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiology 1992; 34: 150-4.
30. Gomori JM, Grossman RI, Goldberg HI, Zimmerman RA, Bilaniuk LT. Intracranial hematomas: imaging by high field MR. Radiology 1985; 157: 87-93.
31. Guadagnino M, Palma V, Tessitore A. Correlation between neuroradiological and electrophysiological investigations in multiple sclerosis with features of a cerebral tumor. Acta Neuopathol (Berl) 1994; 16: 19-28.
32. Gupta RK, Jena A, Sharma A, Guha DK, Khushu S, Gupta AK. MR imaging of intracranial tuberculomas. J Comput Assist Tomogr 1988; 12: 28-285.
33. Gutling E, Landis T. CT ring sign imitating tumour, disclosed as multiple sclerosis by MRI: a case report. J Neurol Neurosurg Psychiatry 1989; 52: 903-6.
34. Haimes AB, Zimmerman RD, Morgello S, Weigarten K, Becker RD, Jennis R, et al. MR imaging of brain abscesses. Am J Roentgenol 1989; 152: 1073-85.
35. Hart M, Earle K. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975; 38: 585-91.
36. Hawkins K, Behrens MM. Homonymous hemianopia in multiple sclerosis with report of bilateral case. Br J Ophthalmol 1975; 59: 334-7.
37. Hayashi T, Kumabe T, Jokura H, Fujihara K, Shiga Y, Watanabe M, et al. Inflammatory demyelinating disease mimicking malignant glioma. J Nucl Med 2003; 44: 565-9.
38. He J, Rgey G, Manon L. Enhancing patterns in multiple sclerosis: evolution and persistence. AJNR Am J Neuroradiol 2001; 22: 64-9.
39. Hershey LA, Gado MH, Trotter JL. Computerized tomography in the diagnostic evaluation of multiple sclerosis. Ann Neurol 1979; 5: 32-9.
40. Hunter S, Ballinger W, Rubin J. Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med 1987; 111: 464-8.
41. Ikeda K, Kinosita M, Kurihara T. An autopsy case of multiple sclerosis of late onset: with a review of the literature. Neurol Med 1992; 36: 589-95.
42. Iniguez C, Pascuall L, Ramon y Cajal S, Fayed N, Morales-Asin F. Transitional multiple sclerosis (Schilder's disease): a case report. J Neurol 2000; 247: 974-6.
43. Iwamoto K, Oka H, Utsuki S, Ozawa T, Fujii K. Late-onset multiple sclerosis mimicking brain tumor: a case report. Brain Tumor pathol 2004; 21: 83-6.
44. Noseworthy J, Paty D, Wonnacott T, Feasby T, Ebers G, et al. Multiple sclerosis after age 50. Neurology 1983; 33: 1537-44.
45. Johnson MD, Lavin P, Whetsell WO Jr. Fulminant monophasic multiple sclerosis, Marburg's type. J Neurol Neurosurg Psychiatry 1990; 53: 918-21.
46. Kalyan-Raman U, Garwacki D, Elwood P. Demyelinating disease of the corpus callosum presenting as glioma on magnetic resonance scan: a case documented with pathologic findings. Neurosurgery 1987; 21: 247-50.
47. Kanaha E, Leibowitz U, Alter M. Cerebral multiple sclerosis. Neurology 1971; 21: 1179-85.
48. Karaarslan E, Altintas A, Senol U, Yeni N, Dincer A, Bayindir C, et al. Balo's concentric sclerosis: clinical and radiologic features of five cases. Am J Neuroradiol 2001; 22: 1362-7.
49. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002; 58: 143-6.
50. Kepes J. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis: a study of 31 patients. Ann Neurol 1993; 33: 18-27.
51. Khoshyomn O, Braff S, Penar P. Tumefactive multiple sclerosis plaque. J Neurol Neurosurg Psychiatry 2002; 73: 85.
52. Kim M, Lee SH, Choi C, Huh J, Lee MC. Balo's concentric sclerosis: a clinical case study of brain MRI, biopsy, and proton magnetic resonance spectroscopic findings. J Neurol Neurosurg Psychiatry 1997; 62: 655-8.
53. Kotil K, Kalaychi M, Koseoglu T, Tugral A. Myelinoclastic diffuse sclerosis (Schilder's disease): report of a case and review of the literature. Br J Neurosurg 2002; 16: 516-9.
54. Kumar K, Toth C, Jay V. Focal plaque of demyelination mimicking cerebral tumor in a pediatric patient. Pediatr Neurol 1998; 29: 60-3.
55. Kurihara N, Takahashi S, Furuta A, Higano S, Matsumoto K, Tobita M, et al. MR imaging of multiple sclerosis simulating brain tumor. Clin Imaging 1996; 20: 171-7.
56. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-11.
57. Lucchinetti CF, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
58. Maranhao-Fiho P, Moraes-Filho LC, Salema C. Fulminant form of multiple sclerosis simulating brain tumor: a case with parkinsonian features and pathologic study. Arq Neuropsiquiatr 1995; 53: 503-8.
59. Martinelli V, Comi G, Filippi M, Rovaris M, Ghezzi A. Paraclinical tests in acute optic neuritis: basal data and results of short term follow-up. Acta Neurol Scand 1991; 84: 231-6.
60. Masdeu JC, Moreira J, Trasi S, Visintainer P, Cavaliere R, Grundman M. The open ring. A new imaging sign in demyelinating disease. J Neuroimaging 1996; 6: 104-7.
61. Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P. Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 2000; 54: 1427-33.
62. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 2003; 61: 1373-7.
63. McAdam LC, Blaser SI, Banwell B. Pediatric tumefactive demyelination: case series and review of the literature. Pediatr Neurol 2002; 26: 18-25.
64. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
65. Metafratzi Z, Argyropoulou MI, Tzoufi M, Papdopoulou Z, Efremidis SC. Conventional MRI and magnetization transfer imaging of tumor-like multiple sclerosis in a child. Neuroradiology 2002; 44: 97-99.
66. Miller DH, Filippi M, Fazekas F, Frederiksen JL, Matthews PM, Montalban X, et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol 2004; 56: 273-8.
67. Miller RC, Lachance DH, Lucchinetti CF, Brown PD, Keegan BM, Bhatia S, et al. Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo clinic experience. Int J Radiat Oncol Biol Phys 2006; 66: 1178-86.
68. Morimoto T, Nagao H, Sano N, Habara S, Takahashi M, Matsuda H, et al. A case of multiple sclerosis with multi-ring-like and butterfly-like enhancement on computerized tomography. Brain Dev 1985; 7: 43-5.
69. Morioka C, Nameta K, Komatsu Y, Tsujio TA, Kondo H. Higher cerebral dysfunction in a case of atypical multiple sclerosis with concentric features. Psychiatry Clin Neurosci 1996; 50: 41-4.
70. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991; 180: 467-74.
71. Niebler G, Harris T, Davis T, Roos K. Fulminant multiple sclerosis. AJNR Am J Neuroradiol 1992; 13: 1547-51.
72. Nyquist PA, Cascino GD, McClelland RL, Annegers J, Rodriguez MI. Incidence of seizures in patients with multiple sclerosis: a population-based study. Mayo Clin Proc 2002; 77: 910-2.
73. O'Brien PC. The appropriateness of analysis of variance and multiple comparison procedures. Biometrics 1983; 39: 787-94.
74. Olmos-Lau N, Ginsberg MD, Geller JB. Aphasia in multiple sclerosis. Neurology 1977; 27: 623-6.
75. Omuro A, Leite C, Mokhtari K, Delattre J. Pitfalls in the diagnosis of brain tumors. Lancet Neurol 2006; 5: 937-48.
76. Paley RJ, Persing JA, Doctor A, Westwater JJ, Roberson JP, Edlich RF. Multiple sclerosis and brain tumor: a diagnostic challenge. J Emerg Med 1989; 7: 241-4.
77. Paolino E, Fainardi E, Ruppi P, Tola MR, Govoni V, Casetta I, et al. A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 572-5.
78. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-5.
79. Perneger TV. What's wrong with Bonferroni adjustments. Br Med J 1998; 316: 1236-8.
80. Peterson K, Rosenblum M, Powers J, Alvord E, Walker R, Posner J. Effect of brain irradiation on demyelinating lesions. Neurology 1993; 43: 2105-12.
81. Pittock SJ, McClelland RL, Achenbach SJ, Konig F, Bitsch A, Bruck W, et al. Clinical course, pathologic correlations and outcome of biopsy proven inflammatory demyelinating disease. J Neurol Neurosurg and Psychiatry 2005; 767: 1693-7.
82. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, et al. Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 2004; 62: 51-9.
83. Poser S, Luer W, Bruhn H, Frahm J, Bruck Y, Felgenhauer K. Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 1992; 86: 579-85.
84. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
85. Rieth K, Di Chiro G, Cromwell L. Primary demyelinating disease stimulating glioma of the corpus callosum. Report of three cases. Neurosurgery 1981; 55: 620-4.
86. Roeltgen DP, Heilman KM, Brennan RW. Aphasia as the presenting symptom of multiple sclerosis. Neurology 1982; 32: A:124.
87. Rolack LA, Beck RW, Paty DW, Tourtellotte NW, Whitaker JN, Rudick RA. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology 1996; 46: 368-72.
88. Rusin JA, Vezina LG, Chadduck WM, Chandra RS. Tumoral multiple sclerosis of the cerebellum in a child. J Neuroradiol 1995; 16: 1164-6.
89. Sagar H, Warlow C, Sheldon P, Esitiri M. Multiple sclerosis with clinical and radiological features of cerebral tumor. J Neurol Neurosurg Psychiatry 1982; 45: 802-8.
90. Savitsky N, Rangell L. On homonymous hemianopia in multiple sclerosis. J Nerve Ment Dis 1950; 111: 225-31.
91. Schwartz K, Erickson BJ, Lucchinetti CF. Pattern of T2 hypointensity associated with ring enhancing brain lesions can help differentiate pathology. Neuroradiology 2006; 48: 143-9.
92. Sharief MK, Thompsen EJ. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann Neurol 1991; 29: 147-51.
93. Stendahl-Brodin L, Link H. Relation between benign course or multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1980; 43: 102-5.
94. Sugita Y, Terasaki M, Shigemori M, Sakata K, Morimatsu M. Acute focal demyelinating disease simulating brain tumors: histopathologic diagnosis for an accurate diagnosis. Neuropathology 2001; 21: 25-31.
95. Tumani H, Tourtellotte WW, Peter JB, Felenhauer K. Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group. J Neurol Sci 1998; 155: 44-9.
96. Weinshenker BG. Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system. J Clin Apheresis 1999; 14: 144-8.
97. Weinshenker BG, Lucchinetti CF. Acute leukoencephalopathies: differential diagnosis and investigation. Neurologist 1998; 4: 148-66.
98. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
99. Wingerchuk D, Pittock S, Lennon V, Lucchinetti C, Weinshenker B. Neuromyelitis optica diagnostic criteria revisited: validation and incorporation of the NMO-IgG serum autoantibody. Neurology 2005; 64: A38.
100. Wurm G, Parsaei B, Silye R, Fellner F. Distinct supratentorial lesions mimicking cerebral gliomas. Acta Neurochir (Wien) 2004; 146: 19-26.
101. Yapici Z, Eraksoy M. Bilateral demyelinating tumefactive lesions in three children with hemiparesis. J Child Neurol 2002; 17: 655-60.
102. Youl BD, Kermode AG, Thompson AJ, Revesz T, Scaravilli F, Barnard RO, et al. Destructive lesions in demyelinating disease. J Neurol Neurosurg Psychiatry 1991; 54: 288-92.
103. Zagzag D, Miller DC, Kelinman GM, Abatic A, Donnenfeld H, Budzilovich GN. Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol 1993; 17: 537-45.
104. Zeman AZJ, Kidd D, McLean BN, Kelly MA, Miller DH, Kendall BE, et al. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 27-30.